Technology News

Synta Pharmaceuticals Files Plan for IPO

Friday, November 24, 2006 6:30:00 AM PDT | VentureDeal Staff

LEXINGTON, MA - Synta Pharmaceuticals Corp. is planning to float its shares in the public markets, according to a recent filing with the SEC.

The filing suggests the company will seek up to $115 million, nearly 18 months after pulling a previous IPO due to uncertain market conditions.

The company has one cancer drug that is near  late-stage trials and several others that are in mid-stage trials for Crohn's disease and cancer.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1